Given that, it's hardly encouraging that Biodexa has taken a big step forward ahead of Recursion in the development of its FAP medication. The latter company's investors will be hoping that REC-4881 ...

Jolene Latimer Leslie Anne Walsh has coached youth, wheelchair curlers, and newcomers of all ages. But the group she meets ...

A new counselling program on P.E.I. hopes to address some of the emotional toll the COVID-19 pandemic left on young people in ...

A new UBC research study led by Dr. Laura Schummers found a 49 per cent jump in the number of "long-acting reversible ...

Mukhtar Latif By Stuart McNish “We have a once in a lifetime opportunity to create Canada’s premier Centre for Excellence in ...